Conference Reports for NATAP

The Liver Meeting AASLD 2024 Nov 15-19, San Diego, CA Back

Phase 3 ESSENCE trial: Semaglutide in metabolic dysfunction-associated steatohepatitis       P.N. Newsome1,2* ,A.J. Sanyal3*, I. Kliers4, L.H Østergaard4, M.T. Long4, M.S. Kjær4, A.M.G. Cali4, E. Bugianesi5, M. Rinella6, M. Roden7-9, V. Ratziu10